| Revenue growth | 7.82% YoY |
|---|---|
| Margins | EBITDA margin at 8.55%; PAT margin at 3.87%. |
| Demand visibility | Strong domestic demand; 94.26% revenue from domestic markets. |
| Management confidence | High; focusing on diversification and sustainable growth. |
Growth
Revenue grew 7.82% YoY to ₹14,153.72 lakhs; PAT increased by 15.47% YoY to ₹552.26 lakhs.
Outlook
Planned Atrazine manufacturing project target: ₹120-140 crore additional annual revenue. Commencing 15 TPD CBG project operations in FY27.
Risks
High working capital requirements impacting export market capture; exposure to hazardous products and global political/environmental disturbances.
Earnings Call filed with NSE, NSE: DHANSA. Summary written with AI assistance from the document.
Dhansa Labs Ltd: key numbers
- Share price
- ₹27.00
- Market cap
- ₹72.64 Cr
- Revenue (annual)
- ₹141.5 Cr
- Net profit (annual)
- ₹5.73 Cr
- P/E (TTM)
- 12.7×Sector 37.5×
- Promoter holding
- 65.05%-5.10% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dhansa Labs Ltd
All →Dhansa Labs Annual General Meeting
Dhansa Labs Limited held its 41st Annual General Meeting on September 26, 2026, to adopt financial statements and ratify the cost auditor's remuneration.
Dhansa Labs Annual General Meeting
Dhansa Labs Limited announced the voting results for its postal ballot. Shareholders approved the alteration of the object clause, asset mortgage/disposal, and a related party transaction.
Dhansa Labs Annual General Meeting
Dhansa Labs Limited issued a notice for its Annual General Meeting scheduled for September 26, 2026. Agenda items include financial statement adoption and director reappointment.
- Value
- ₹0.01 Cr
Dhansa Labs Q1 FY27 Results: Net Profit ₹1.3 Cr, Up 8.3% YoY
Dhansa Labs Ltd reported revenue from operations of ₹30.6 Cr (+8.1% YoY) and net profit of ₹1.3 Cr (+8.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.3 Cr · +8.3% YoY
Dhansa Labs Earnings Call: Key Takeaways
Dhansa Labs reported FY26 revenue of ₹141.5cr (up 10.8% YoY) and PAT of ₹5.5cr (up 15.5% YoY). Strategy shifts toward diversification into renewable energy and agrochemical capacity expansion.
Dhansa Labs Earnings Call: Key Takeaways
Dhansa Labs reports FY26 revenue growth of 10.82% while aggressively pivoting into capital-intensive green energy and biofuels via new subsidiaries.